Stay updated on Immunotherapy in Resectable Head & Neck SCC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy in Resectable Head & Neck SCC Clinical Trial page.

Latest updates to the Immunotherapy in Resectable Head & Neck SCC Clinical Trial page
- ChecktodayChange DetectedThe page revision tag was updated to v3.5.4, indicating an editorial update to the page's content or metadata. This reflects a version bump rather than a substantive change to the study details.SummaryDifference0.0%

- Check8 days agoChange DetectedAdded TP53-focused outcome analyses for Cohort 1, specifying EFS and OS differences by TP53 status. This replaces the prior broader presence/absence approach with a gene-specific analysis in the first cohort.SummaryDifference0.3%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, reflecting a site update rather than any change to the underlying study information.SummaryDifference0.0%

- Check29 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing Revision: v3.4.3.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy in Resectable Head & Neck SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy in Resectable Head & Neck SCC Clinical Trial page.